Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 590 results for "biocon"

India Value Fund buys 10% in Biocon's research subsidiary Syngene
Business Standard

Silver Leaf Oak pays ₹380 cr for 10% in Biocon's R&D arm

Silver Leaf Oak has acquired a 10 per cent stake in Syngene International, the research subsidiary of Biocon, and signals a step towards the arm's listing on stock exchanges. As part of this transaction, Mauritius-based Silver Leaf, an investment ... Hindu Business Line, 6 hours ago

35 images for biocon

Financial Express, 1 week ago
Money Control, 9 hours ago
4 Traders, 1 week ago
Asian Scientist, 1 week ago
Business Times Singapore, 1 week ago
Business Standard, 5 hours ago, 1 week ago
NDTV, 1 week ago
Business Standard India, 3 weeks ago, 3 weeks ago

India Value Fund buying 10% in Biocon's research arm Syngene for $62M

Mid-market buyout specialist private equity firm India Value Fund Advisors (IVFA) is picking 10 per cent stake in Syngene International Ltd, a step down research subsidiary of Biocon Ltd, for Rs 380 crore ($62.2 million). VCCircle had first ...
 VC Circle8 hours ago India Value Fund Advisors to pick up 10% stake in Biocon unit  Livemint.com10 hours ago BRIEF: India Value Fund Advisors to pick up 10% stake in Biocon unit [Mint, New Delhi :: ]  BusinessWeek10 hours ago

Silver Leaf to pick up stake in Biocon arm

Comment · print · T T T+· T- The Hindu Kiran Mazumdar-Shaw TOPICS Biocon, on Thursday, said Silver Leaf Oak (Mauritius) Ltd. is picking up a 10 per cent stake in Syngene International Limited, its research services subsidiary. ...
 The Hindu5 hours ago

BHEL, Crompton, Arvind, Biocon to get astro support: Gupta

According to Satish Gupta of, capital goods stocks like Crompton Greaves, Siemens, ABB, Bharat Heavy Electricals and Havells India will be getting astrological support.
 Money Control17 hours ago Dr Reddy's, Lupin, BOI, SBI to get astro support: Gupta  Money Control2 days ago Biocon, Dr Reddy's, TCS to get astro support: Gupta  Money Control1 month ago Maruti, Tata Motors, Biocon to get astro support: Gupta  Money Control1 month ago

Biocon up 3% post Mylan's phase-3 trials for Glargine

Kiran Mazumdar Shaw, CMD of the company sees it to be a huge opportunity in the diabetic market and expects the insulin analogue market to grow in double-digits.
 Money Control1 day ago Looking to commercialise insulin Glargine by 2018: Biocon  Money Control1 day ago Looking to commercialise Galrgine by 2018: Biocon's Shaw  Money Control1 day ago Biocon-Mylan start global phase-3 trials for drug Glargine  Money Control1 day ago
Money Control

Be Passionate, Execute Biz Ideas: Shaw

BANGALORE: Biocon Chairperson Kiran Mazumdar-Shaw said that the Union government is doing its best for the development of trade and businesses within and outside the country. Speaking at an interactive session organised for students by Enactus, a ...
 New Indian Express1 week ago NPPA's unilateral stand-off unhealthy for sector: Biocon  Money Control1 month ago Price control debate: Is the pharma sector crying 'wolf'?  Money Control2 months ago Exempt biotech, pharma from service tax, MAT: Kiran Mazumdar Shaw  DNA2 months ago

Biocon, Glenmark Pharma, Arvind to get astro support: Gupta

According to Satish Gupta of, pharma stocks like Biocon, Glenmark Pharma, Aurobindo Pharma, Divis Laboratories and Cipla will be getting astro support.
 Money Control1 week ago Cipla, TCS, Ranbaxy, Polaris to get astro support: Gupta  Money Control3 weeks ago Cipla, Ranbaxy, Shree Renuka to get astro support: Gupta  Money Control2 months ago Shares of pharma cos fall of FDA inspection report in Sun Pharma  India Infoline1 week ago

Biocon slips on profit booking

on profit booking after the stock rose 8.45% in the preceding eight trading sessions to Rs 504 on 10 September 2014, from a recent low of Rs 464.75 on 28 August 2014. Meanwhile, the BSE Sensex was down 1.96 points, or 0.01%, to 27,055.45. On BSE, so ...
 Business Standard India1 week ago

Biocon shares up on Syngene stake purchase

Reuters Market Eye - Biocon Ltd (BION.NS: Quote, Profile, Research) shares up 1 percent.* The drugmaker has agreed to buy a 7.7 percent stake in its research services business from a unit of GE Capital. Biocon would fully own Syngene after the ...
 Reuters India1 week ago
Asian Scientist

Biocon Runs Free Oral Cancer Screens In India

Tech & Pharma September 10, 2014 Biocon organized a week of free oral cancer screening activities across 23 Indian cities from September 1-7, 2014. AsianScientist (Sep. 10, 2014) Biocon Ltd, a biopharmaceuticals company headquartered in ...
 Asian Scientist1 week ago Free Cancer Screening Camp  New Indian Express2 weeks ago Indian Dental Association to organize oral cancer screening camp  Times of India2 weeks ago BIOCON : Kick-Starts Free Oral Cancer Screening Programs Across India  4 Traders2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less